|
PART
|
96T
|
48T
|
STORAGE
|
|
Pre-Coated Plate
|
8×12
|
8×6
|
4 ℃ / -20 ℃
|
|
Pre-Mixed Standards
|
2 vials
|
1 vial
|
4 ℃ / -20 ℃
|
|
Pre-Mixed Biotinylated Antibody (1:100)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Enzyme Conjugate(1:100)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Enzyme Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Antibody Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Standard Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Sample Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Washing Buffer (1:25)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent A
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent B
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent C
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Manual
|
1 set
|
1 set
|
RT
|
Place collected whole blood in refrigerator at 4 ℃ overnight. Then centrifuge for 10mins at 1000-3000 rpm. Take supernatant and either test immediately or place samples at -20 ℃/-80 ℃(1-3 months) for storage.
Take plasma where EDTA, sodium citrate, or heparin has been added as anticoagulant. Mix well. Centrifuge mixture for 10mins at 1000-3000 rpm. Take supernatant and test immediately or place samples at -20 ℃ /-80 ℃ (1-3 months) for storage.
Take tissue slices which have been washed in 0.01 M PBS and then a tissue protein extraction reagent has been added according to proportion of 1 g to 5-10 mL and then mixed on ice bath. After sufficient homogenization, please then centrifuge for 10mins at 5000-10000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
Centrifuge for 10 mins at 1000-3000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
Centrifuge for 10mins at 1000-3000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
|
TYPICAL DATA
|
Reference STD1
|
Reference STD2
|
Reference STD3
|
Reference STD4
|
Reference STD5
|
Reference STD6
|
Reference STD7
|
Reference STD8
|
|
IRAK, pg/mL
|
500
|
250
|
125
|
62.5
|
31.25
|
15.625
|
7.813
|
0
|
|
IRAK, OD.
|
2.517
|
1.398
|
0.777
|
0.432
|
0.24
|
0.133
|
0.074
|
0.049
|
|
IL-1R1, pg/mL
|
500
|
250
|
125
|
62.5
|
31.25
|
15.625
|
7.813
|
0
|
|
IL-1R1, OD.
|
3.106
|
1.726
|
0.959
|
0.533
|
0.296
|
0.164
|
0.091
|
0.061
|
|
IL-1RII, pg/mL
|
500
|
250
|
125
|
62.5
|
31.25
|
15.625
|
7.813
|
0
|
|
IL-1RII, OD.
|
2.564
|
1.424
|
0.791
|
0.44
|
0.244
|
0.136
|
0.075
|
0.05
|
|
IL-1, pg/mL
|
500
|
250
|
125
|
62.5
|
31.25
|
15.625
|
7.813
|
0
|
|
IL-1, OD.
|
3.239
|
1.799
|
1
|
0.555
|
0.309
|
0.171
|
0.095
|
0.063
|
STANDARD CURVE
To assess linearity of the assay, samples were spiked with high concentrations of Human IRAK, IL-1R1, IL-1RII, IL-1 and diluted with the appropriate calibrator diluent to produce samples with values within the dynamic range of the assay.
|
Matrix
|
Scope %
|
Average % Recovery Rate
|
|
serum(n=5)
|
82-95
|
88.5
|
|
EDTA plasma(n=5)
|
85-101
|
93
|
|
Cell Culture Media(n=5)
|
90-105
|
97.5
|
|
Within-Run Precision
|
Inter-Batch Precision
|
|||||
|
Sample
|
1
|
2
|
3
|
1
|
2
|
3
|
|
n
|
20
|
20
|
20
|
20
|
20
|
20
|
|
CV%
|
6.5
|
6.2
|
6.5
|
8.8
|
8.1
|
8.7
|